2025 HCPCS Code J9349
Injection, tafasitamab-cxix, 2 mg
| Short Description | Inj., tafasitamab-cxix |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | April 01, 2021 |
| HCPCS Action Effective Date | April 01, 2021 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J7520 - Sirolimus, oral
- J7525 - Tacrolimus injection
- J7527 - Oral everolimus
- J7599 - Immunosuppressive drug noc
- J7604 - Acetylcysteine comp unit
- J7605 - Arformoterol non-comp unit
- J7606 - Formoterol fumarate, inh
- J7607 - Levalbuterol comp con
- J7608 - Acetylcysteine non-comp unit
- J7609 - Albuterol comp unit
- J7610 - Albuterol comp con
- J7611 - Albuterol non-comp con
- J7612 - Levalbuterol non-comp con
- J7613 - Albuterol non-comp unit
- J7614 - Levalbuterol non-comp unit
- J7615 - Levalbuterol comp unit
- J7620 - Albuterol ipratrop non-comp
- J7622 - Beclomethasone comp unit
- J7624 - Betamethasone comp unit
- J7626 - Budesonide non-comp unit